Marker for predicting prognosis of cancer patients and application of marker
A marker and cancer technology, applied in the field of biomedicine, can solve the problems of reducing total mortality and low accuracy
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0063] Example 1 Screening of differentially expressed genes associated with survival of endometrial cancer patients
[0064] 1. Dataset
[0065] The sequencing data of 333 endometrial cancer patients published in nature in the TCGA database were used as the analysis data set (Uterine Corpus Endometrial Carcinoma (TCGA, Nature 2013)).
[0066] 2. Analysis method
[0067] There are 52 patients with advanced (stage III, IV) endometrial adenocarcinoma in the TCGA database. The grouping strategy considers that the cases with an overall survival of more than 5 years are high-survival cases. There are 11 cases in total, and the overall survival is less than 2 years. The patients who died were low survival cases, with a total of 4 cases. The correlation R language package (edgeR) was used to obtain the differentially expressed genes between long-survival patients and short-survival patients of endometrial adenocarcinoma (the absolute value of the Pearson correlation coefficient wit...
Embodiment 2
[0074] Example 2 Correlation between FAM65B gene and survival of patients with lung adenocarcinoma
[0075] 1. Dataset
[0076] Lung Adenocarcinoma (TCGA, PanCancer Atlas) was used for analysis.
[0077] 2. Analysis method
[0078] Survival analysis and ROC curve analysis were carried out on the differentially expressed gene FAM65B of high and low survival patients with endometrial cancer screened in patients with lung adenocarcinoma. Value) ≥ 0.55 can be used as a model to predict the length of patient survival.
[0079] 3. Results
[0080] The results of the patient survival analysis were image 3 As shown, the survival period of lung adenocarcinoma patients with high expression of FAM65B gene is longer, and the survival period of lung adenocarcinoma patients with low expression of FAM65B gene is shorter, the difference is statistically significant (P=0.0012), and the prognosis of patients with high expression of FAM65B gene is obvious Better than patients with low FAM6...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com